[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Fact Point @FactPoint on x 396.7K followers
Created: 2025-07-19 09:31:07 UTC
Japanese scientists, led by Dr. Hideyuki Okano at Keio University, have gained regulatory approval for a human trial using induced pluripotent stem cells, which are adult cells reprogrammed to behave like embryonic stem cells. This marks a significant step forward in regenerative medicine.
XXX engagements
